Brief: Oryzon Strengthens Patent Portfolio For Iadademstat With European Grant Decision Covering Combinations With Pd1/Pd-L1 Inhibitors

ORYZON Genomics SA

01/10/2025 07:12

Oct 1 (Reuters) - Oryzon Genomics SA ORY.MC:

STRENGTHENS PATENT PORTFOLIO FOR IADADEMSTAT WITH EUROPEAN GRANT DECISION COVERING COMBINATIONS WITH PD1/PD-L1 INHIBITORS

PATENT WILL REMAIN IN FORCE UNTIL AT LEAST 2040, EXCLUDING POTENTIAL PATENT TERM EXTENSIONS

Source text

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))